Atorvastatin Calcium Tablet, Film Coated
Product Images NDC 71335-3144

View Photos of Packaging, Regulatory Labels, and Product Appearance

Product Visual Gallery

This gallery contains 5 technical images submitted to the FDA as part of the official labeling for Atorvastatin Calcium (NDC 71335-3144). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Bryant Ranch Prepack, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Figure1 (Atorvastatin Figure1)

Figure1 (Atorvastatin Figure1)
A line graph illustrating the effect of Atorvastatin 10 mg/day on cumulative incidence of non-fatal myocardial infarction or coronary heart disease death over approximately 3.5 years, comparing Atorvastatin (solid line) and placebo (dashed line). The Y-axis shows cumulative incidence percentage, while the X-axis represents time in years.*
FDA Label Image

Figure2 (Atorvastatin Figure2)

Figure2 (Atorvastatin Figure2)
A Kaplan-Meier curve chart showing the effect of Atorvastatin 10 mg/day on time to occurrence of major cardiovascular events (myocardial infarction, acute CHD death, unstable angina, coronary revascularization, or stroke) in the CARDS study. The chart plots cumulative hazard percentage versus time in years for Atorvastatin compared to placebo, showing a lower cumulative hazard over four years of follow-up with Atorvastatin (HR 0.63, p=0.001).*
FDA Label Image

Figure3 (Atorvastatin Figure3)

Figure3 (Atorvastatin Figure3)
A line graph comparing the effect of Atorvastatin 80 mg/day versus 10 mg/day on the time to occurrence of major cardiovascular events. The x-axis represents time to first major cardiovascular endpoint in years, and the y-axis shows the percentage of subjects experiencing the event. Two lines depict Atorvastatin 10 mg (dashed) and 80 mg (solid) with event rates increasing over time.*
FDA Label Image

Structure (Atorvastatin Structure)

Structure (Atorvastatin Structure)
Chemical structure diagram of Atorvastatin Calcium, showing its molecular composition including phenyl rings, fluorine atom, calcium ion, and water molecules associated as hydrates.*
FDA Label Image

Label (Lbl713353144)

Label (Lbl713353144)
Atorvastatin Calcium Tablets, USP 10 mg film-coated tablets label. The package contains 30 tablets and is labeled as prescription only. It is repackaged by Bryant Ranch Prepack, Inc., Burbank, CA, and manufactured by Laurus Labs Limited. The label includes storage instructions and QR codes for packaging and patient information.*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.